Now showing items 1-3 of 3

    • Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi Sarcoma in Kenya: A cost-effectiveness analysis 

      Freeman, Esther E.; McCann, Nicole C.; Semeere, Aggrey; Reddy, Krishna P.; Laker-Oketta, Miriam; Byakwaga, Helen; Pei, Pamela P.; Fernandez, Maya E Hajny; Kiprono, Samson; Busakhala, Naftali; Martin, Jeffery N; Maurer, Toby; Bassett, Ingrid V.; Freedberg, Kenneth A.; Hyle, Emily P. (Elsevier, 2022)
      Background The most effective treatment for advanced AIDS-associated Kaposi sarcoma is paclitaxel or pegylated liposomal doxorubicin (PLD); neither is routinely used in sub-Saharan Africa due to limited availability and ...
    • Telling the story of intersectional stigma in HIV-associated Kaposi’s sarcoma in Western Kenya: A convergent mixed-methods approach 

      Collier, Sigrid; Singh, Rhea; Semeere, Aggrey; Byakwaga, Helen; Laker-Oketta, Miriam; McMahon, Devon E.; Chemtai, Linda; Grant, Merridy; Butler, Lisa; Bogart, Laura; Bassett, Ingrid V.; Kiprono, Samson; Maurer, Toby; Martin, Jeffrey; Busakhala, Naftali; Freeman, Esther E. (Wiley Online Library, 2022)
      Introduction: The experience of stigma can be multifaceted for people with HIV and cancer. Kaposi’s sarcoma (KS), one of the most common HIV-associated cancers in sub-Saharan Africa, often presents with visible skin lesions ...
    • Understanding diagnostic delays for kaposi sarcoma in Kenya: A qualitative study 

      McMahon, Devon E.; Chemta, Linda; Grant, Merridy; Singh, Rhea; Semeere, Aggrey  ; Byakwaga, Helen; Laker-Oketta, Miriam; Maurer, Toby; Busakhala, Naftali; Martin, Jeffrey; Bassett, Ingrid V.; Butler, Lisa; Freeman, Esther E. (2022)
      Background: Although HIV-associated Kaposi sarcoma (KS) is frequently diagnosed at an advanced stage in sub-Saharan Africa, reasons for diagnostic delays have not been well described. Methods: We enrolled patients >18 years ...